BCN Biosciences is a preclinical biotechnology corporation with core competency in the oncology drug discovery and development market. Our mission is to improve cancer treatment and diagnosis by advancing new therapeutics. BCN Biosciences employs its leading talent for the development and commercialization of both small molecule and biological therapeutic candidates. BCN possesses an experienced team of drug discovery and oncology experts coupled with a commitment to developing novel and effective medicines to prevent and treat cancer, one of world's most serious diseases. BCN Biosciences is also partnering with the United States Government to develop drugs that counter acute radiation syndrome (ARS).
BCN Biosciences featured as a technology innovator in Innovate Pasadena.